Skip to main content

April 2023

 

 

academics

 

Clinical research courses

AIOCD writes DCGI on irregularities by online pharmacy continues

The All India Organisation of Chemists & Druggists (AIOCD) has written to the Drug Controller General of India (DCGI) on operations of online Pharmacies. AIOCD stated that despite the issuance of notices, E-Pharmacy companies have not stopped their operations.

Job for Pharmacists (22 posts) under District Health Committee

Keeping in view the requirement of ANM and other paramedical personnel for the operation of various health institutions, newly constructed non-created health institutions and newly proposed malnutrition treatment centers under District Latehar, provisionally and temporarily on the basis of contract / contract, the mercury workers mentioned below and For selection/appointment on other block and district level posts, applications are invited through registered post/speed post from the local candidates of Jharkhand state as follows.

Multiple Openings at NADA - Ministry of Youth Affairs & Sports | Pay upto Rs. 1,00,000 pm

National Anti-Doping Agency is an autonomous body of the Ministry of Youth Affairs & Sports, Government of India. NADA is responsible for promoting, coordinating and monitoring the doping control programme in sports in all its forms across the country.

Post : Senior Programme Associate, Programme Associate, Research Associate, Sr Scientific Officer

Life Sciences Recruitment at National AIDS Research Institute

ICMR-NARI is located at Bhosari, Pune on a seven acre plot. Since its inception the Institute has ably supported the National AIDS Control Programme, especially in the areas of surveillance, capacity building, laboratory services and drug resistance studies. ICMR-NARI derives strength from wide ranging National and International Collaborations.  The Institutes research activities are guided by a Scientific Advisory Committee which includes eminent scientists from varied disciplines.

Walk in Drive for B.Pharm, M.Pharm, MSc in Production, QA, QC, Packing at Zydus Life Sciences

After a journey of growth spanning 27 years as Cadila Healthcare Ltd. and the Zydus Group, we have evolved and transformed ourselves in response to the changing times. Our legacy of over 70 years in healthcare and being dedicated to life in all its dimensions is reaffirmed in our new mission, vision and purpose. Unifying ourselves under the Zydus name, Cadila Healthcare Ltd., is renamed as Zydus Lifesciences Ltd.

Walk-in Interview at Indore || Zydus Lifesciences Ltd. || Moraiya

Novartis looking for Expert Scientific Writer - Ph.D, M.Pharm, MSc Apply

Novartis has one of the most exciting product pipelines in the industry today. A pipeline of innovative medicines brought to life by diverse, talented and performance driven people. All of which makes them one of the most rewarding employers in their field. 

Post : Expert Scientific Writer

Clarivate Hiring Associate Content Editor - MS or PhD in pharmacology Apply

Clarivate is a global leader in providing solutions to accelerate the lifecycle of innovation. Our bold mission is to help customers solve some of the world's most complex problems by providing actionable information and insights that reduce the time from new ideas to life-changing inventions in the areas of science and intellectual property. We help customers discover, protect and commercialize their inventions using our trusted subscription and technology-based solutions coupled with deep domain expertise.

Require Expert Medical Regulatory Writer at Sanofi

Sanofi is dedicated to supporting people through their health challenges. We are a global biopharmaceutical company focused on human health. We prevent illness with vaccines, provide innovative treatments to fight pain and ease suffering. With more than 100,000 people in 100 countries, Sanofi is transforming scientific innovation into healthcare solutions around the globe.

Post : Expert Medical Regulatory Writer

Sanofi, AstraZeneca and Sobi simplify contractual agreements of Nirsevimab

Sanofi has simplified its contractual arrangements relating to the development and commercialization of Beyfortus (nirsevimab) in the United States (U.S.).

Under the new and updated arrangements, Sobi will terminate its participation agreement with AstraZeneca, and Sanofi and AstraZeneca will update the Collaboration Agreement so that Sanofi has full commercial control of nirsevimab in the U.S. Sanofi has simultaneously entered into a direct royalty agreement with Sobi to share a portion of U.S. net sales from nirsevimab.

Lupin opens regional lab in Bengaluru

Lupin Limited announced the launch of its new state-of-the-art Regional Reference Laboratory in Bengaluru, Karnataka, as part of the expansion of its diagnostics network. The new laboratory marks a significant step forward in Lupin Diagnostics' mission to provide accessible and affordable diagnostics and preventive healthcare services across India. The Regional Reference Laboratory complements the company's existing network of 25 laboratories and 410+ collection centers across India.